Sugi Predict

Sugi Predict / Compounds / SCHEMBL5576894

SCHEMBL5576894

SCHEMBL5576894

COC(=O)[C@@H](NC(=O)CNC(=O)OC(C)(C)C)[C@@H](C)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KLK5 Q9Y337 2/20 0.44
▸ CTSS P25774 3/20 0.40
▸ CTSK P43235 3/20 0.40
▸ CA12 O43570 3/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ PSENEN Q9NZ42 1/20 0.39
▸ CA1 P00915 3/20 0.39
▸ CA2 P00918 3/20 0.39
▸ CA7 P43166 1/20 0.39
▸ CYP2D6 P10635 1/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ SDCBP O00560 1/20 0.37
▸ SDC2 P34741 1/20 0.37
▸ CA9 Q16790 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ CTSL P07711 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2255391 1.00 KLK5 (0.44) KLK5CTSSCTSKCA12CA14
SCHEMBL14146391 0.95 PSENEN (0.43) KLK5CTSSCTSKCA12CA14
SCHEMBL16667727 0.90 KLK5 (0.50) KLK5CTSSCTSKCA12CA14
SCHEMBL25652880 0.90 KLK5 (0.50) KLK5CTSSCTSKCA12CA14
SCHEMBL9980711 0.87 KMT2A (0.45) KLK5CTSSCTSKCA1CA2
SCHEMBL17238024 0.86 PSENEN (0.53) KLK5CTSSCTSKPSENENCA2
SCHEMBL22636430 0.86 PSENEN (0.53) KLK5CTSSCTSKPSENENCA2
SCHEMBL17238160 0.86 PSENEN (0.53) KLK5CTSSCTSKPSENENCA2
SCHEMBL18764870 0.86 KLK5 (0.42) KLK5CTSSCTSKCA12CA14
SCHEMBL18782182 0.86 KLK5 (0.42) KLK5CTSSCTSKCA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120289520-A1 CHEMICAL COMPOUNDS 785 ASTRAZENECA AB (SE) 2012-11-15 — — US disclosed
US-8188092-B2 Substituted pyrazines as DGAT-1 inhibitors ASTRAZENECA AB (SE) 2012-05-29 — — US disclosed
US-8188092-B2 Substituted pyrazines as DGAT-1 inhibitors ASTRAZENECA AB (SE) 2012-05-29 — — US disclosed
US-20120108602-A1 Carbamoyl Compounds as DGAT1 Inhibitors 190 ASTRAZENECA AB (SE) 2012-05-03 — — US disclosed
US-7994179-B2 Carbamoyl compounds as DGAT1 inhibitors 190 ASTRAZENECA AB (SE) 2011-08-09 — — US disclosed
US-7994179-B2 Carbamoyl compounds as DGAT1 inhibitors 190 ASTRAZENECA AB (SE) 2011-08-09 — — US disclosed
US-20100324068-A1 CHEMICAL COMPOUNDS 785 ASTRAZENECA AB (SE) 2010-12-23 — — US disclosed
US-20100324068-A1 CHEMICAL COMPOUNDS 785 ASTRAZENECA AB (SE) 2010-12-23 — — US disclosed
US-20090298853-A1 Carbamoyl Compounds as DGAT1 Inhibitors 190 ASTRAZENECA AB (SE) 2009-12-03 — — US disclosed
US-20090298853-A1 Carbamoyl Compounds as DGAT1 Inhibitors 190 ASTRAZENECA AB (SE) 2009-12-03 — — US disclosed
WO-2009081195-A1 CARBAMOYL COMPOUNDS AS DGAT1 INHIBITORS 190 ASTRAZENECA AB (SE) 2009-07-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108602-A1 Carbamoyl Compounds as DGAT1 Inhibitors 190 DGAT1, DGAT2, SOAT1 KLK5 4530/4885CTSS 1910/4885CTSK 1600/4885
US-20100324068-A1 CHEMICAL COMPOUNDS 785 GPBAR1, DGAT1, GPR119 KLK5 2623/4885CTSS 890/4885CTSK 1910/4885
US-20090298853-A1 Carbamoyl Compounds as DGAT1 Inhibitors 190 DGAT1, DGAT2, SOAT1 KLK5 4529/4885CTSS 1902/4885CTSK 1596/4885
US-20120289520-A1 CHEMICAL COMPOUNDS 785 DGAT1, DGAT2, SLC5A1 KLK5 1045/4885CTSS 1653/4885CTSK 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.